Lineage Cell Therapeutics, Inc. - stock earnings
LCTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -4.8 million USD | 2.1 million USD |
| 2023Q3 | -7.1 million USD | 1.2 million USD |
| 2023Q2 | -5.2 million USD | 3.2 million USD |
| 2023Q1 | -4.4 million USD | 2.4 million USD |
| 2022Q4 | -6.6 million USD | 1.9 million USD |
| 2022Q3 | -6.1 million USD | 3.0 million USD |
| 2022Q2 | -10.0 million USD | 4.6 million USD |
| 2022Q1 | -8.3 million USD | 5.2 million USD |
| 2021Q4 | -29.0 million USD | 960000 USD |
| 2021Q3 | -7.8 million USD | 2.2 million USD |
| 2021Q2 | -4.8 million USD | 441000 USD |
| 2021Q1 | -1.4 million USD | 293000 USD |
| 2020Q4 | 2.0 million USD | 166000 USD |
| 2020Q3 | -7.8 million USD | 342000 USD |
| 2020Q2 | -6.5 million USD | 99000 USD |
| 2020Q1 | -8.4 million USD | 166000 USD |
| 2019Q4 | -4.5 million USD | 832000 USD |
| 2019Q3 | -16.5 million USD | 217000 USD |
| 2019Q2 | -30.0 million USD | 250000 USD |
| 2019Q1 | 39.3 million USD | 179000 USD |
| 2018Q4 | -45.0 million USD | 171000 USD |
| 2018Q3 | 66.7 million USD | 264000 USD |
| 2018Q2 | -4.2 million USD | 606000 USD |
| 2018Q1 | -63.5 million USD | 375000 USD |
| 2017Q4 | -71.9 million USD | 569000 USD |
| 2017Q3 | 14.3 million USD | 463000 USD |
| 2017Q2 | -11.7 million USD | 381000 USD |
| 2017Q1 | 49.3 million USD | 379000 USD |
| 2016Q4 | -5.1 million USD | 758000 USD |
| 2016Q3 | 31.2 million USD | 390000 USD |
| 2016Q2 | 24.5 million USD | 506000 USD |
| 2016Q1 | -17.1 million USD | 586000 USD |
| 2015Q4 | -13.4 million USD | 555000 USD |
| 2015Q3 | -13.6 million USD | 840000 USD |
| 2015Q2 | -9.7 million USD | 572000 USD |
| 2015Q1 | -10.2 million USD | 565615 USD |
| 2014Q4 | -10.6 million USD | 444204 USD |
| 2014Q3 | -8.3 million USD | 543523 USD |
| 2014Q2 | -9.5 million USD | 466666 USD |
| 2014Q1 | -8.1 million USD | 490976 USD |
| 2013Q4 | -19.6 million USD | 1.3 million USD |
| 2013Q3 | -9.0 million USD | 553631 USD |
| 2013Q2 | -7.5 million USD | 522845 USD |
| 2013Q1 | -7.7 million USD | 524147 USD |
| 2012Q4 | -6.0 million USD | 518165 USD |
| 2012Q3 | -5.0 million USD | 1.0 million USD |
| 2012Q2 | -5.5 million USD | 1.0 million USD |
| 2012Q1 | -5.0 million USD | 631946 USD |
| 2011Q4 | -5.4 million USD | 1.6 million USD |
| 2011Q3 | -3.7 million USD | 1.1 million USD |
| 2011Q2 | -4.3 million USD | 755553 USD |
| 2011Q1 | -3.4 million USD | 824629 USD |
| 2010Q4 | -3.0 million USD | 1.4 million USD |
| 2010Q3 | -4.7 million USD | 815284 USD |
| 2010Q2 | -2.3 million USD | 680278 USD |
| 2010Q1 | -1.3 million USD | 767127 USD |
| 2009Q4 | 1.4 million USD | 749341 USD |
| 2009Q3 | -3.6 million USD | 446993 USD |
| 2009Q2 | -1.5 million USD | 432090 USD |
| 2009Q1 | -1.5 million USD | 296743 USD |
| 2008Q4 | -1.6 million USD | 285280 USD |
| 2008Q3 | -1.1 million USD | 426931 USD |
| 2008Q2 | -662780 USD | 410563 USD |
| 2008Q1 | -326796 USD | 358523 USD |
| 2007Q4 | -326796 USD | 358523 USD |
| 2007Q3 | -213491 USD | 231159 USD |
| 2007Q2 | -344077 USD | 210741 USD |
| 2007Q1 | -378555 USD | 480082 USD |
| 2006Q4 | -378555 USD | 480082 USD |
| 2006Q3 | -340035 USD | 296996 USD |
| 2006Q2 | -667844 USD | 143195 USD |
| 2006Q1 | -489870 USD | 222410 USD |
| 2005Q4 | -489870 USD | 222410 USD |
| 2005Q3 | -415058 USD | 240432 USD |
| 2005Q2 | -442734 USD | 249274 USD |
| 2005Q1 | -726590 USD | 191083 USD |
| 2004Q4 | -548054 USD | 191959 USD |
| 2004Q3 | -452060 USD | 170381 USD |
| 2004Q2 | -442268 USD | 195337 USD |
| 2004Q1 | -1.6 million USD | 130700 USD |
| 2003Q4 | -598093 USD | 252634 USD |
| 2003Q3 | 362020 USD | 109870 USD |
| 2003Q2 | -754872 USD | 97297 USD |
| 2003Q1 | -751129 USD | 96622 USD |
| 2002Q4 | -776479 USD | 183130 USD |
| 2002Q3 | -578864 USD | 85843 USD |
| 2002Q2 | -783181 USD | 60812 USD |
| 2002Q1 | -622023 USD | 52848 USD |
| 2001Q4 | -622023 USD | 52848 USD |
| 2001Q3 | -903367 USD | 36416 USD |
| 2001Q2 | -1.1 million USD | 29958 USD |
| 2001Q1 | -951739 USD | 32695 USD |
| 2000Q4 | -1.1 million USD | 52491 USD |
| 2000Q3 | -1.2 million USD | 1 USD |
| 2000Q2 | -1.3 million USD | 1 USD |
| 2000Q1 | -1.3 million USD | 1 USD |
| 1999Q4 | -1.5 million USD | 37500 USD |
| 1999Q3 | -2.3 million USD | 100000 USD |
| 1999Q2 | -1.0 million USD | 600000 USD |
| 1999Q1 | -800000 USD | 400000 USD |
| 1998Q4 | -960000 USD | 130000 USD |
| 1998Q3 | -1.1 million USD | 100000 USD |
| 1998Q2 | -800000 USD | 400000 USD |
| 1998Q1 | -1.1 million USD | 100000 USD |
| 1997Q4 | -600000 USD | 500000 USD |
| 1997Q3 | -1.0 million USD | 100000 USD |
| 1997Q2 | -1.0 million USD | ? USD |
| 1997Q1 | -500000 USD | 100000 USD |
| 1996Q4 | -800000 USD | 100000 USD |
| 1996Q3 | -700000 USD | 100000 USD |
| 1996Q2 | -500000 USD | ? USD |
| 1996Q1 | -600000 USD | 100000 USD |
| 1995Q4 | -600000 USD | 100000 USD |
| 1995Q3 | -300000 USD | 100000 USD |
| 1995Q2 | -700000 USD | ? USD |
| 1995Q1 | -600000 USD | 100000 USD |
| 1994Q4 | -600000 USD | 100000 USD |
| 1994Q3 | -500000 USD | 100000 USD |
| 1994Q2 | -400000 USD | ? USD |
| 1994Q1 | -300000 USD | 100000 USD |
| 1993Q4 | -400000 USD | 100000 USD |
| 1993Q3 | -300000 USD | 100000 USD |
| 1993Q2 | -300000 USD | ? USD |
| 1993Q1 | -200000 USD | 100000 USD |
| 1992Q4 | -300000 USD | 100000 USD |
| 1992Q3 | -300000 USD | 100000 USD |
| 1992Q2 | -200000 USD | ? USD |
| 1992Q1 | -200000 USD | 100000 USD |
LCTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.5 million USD | 8.9 million USD |
| 2022 | -26.4 million USD | 14.7 million USD |
| 2021 | -38.6 million USD | 3.9 million USD |
| 2020 | -20.7 million USD | 773000 USD |
| 2019 | -11.8 million USD | 1.5 million USD |
| 2018 | -46.0 million USD | 1.4 million USD |
| 2017 | -20.0 million USD | 1.8 million USD |
| 2016 | 33.6 million USD | 2.3 million USD |
| 2015 | -47.0 million USD | 2.5 million USD |
| 2014 | -36.4 million USD | 1.9 million USD |
| 2013 | -43.9 million USD | 2.9 million USD |
| 2012 | -21.4 million USD | 1.7 million USD |
| 2011 | -16.5 million USD | 4.4 million USD |
| 2010 | -11.2 million USD | 3.7 million USD |
| 2009 | -5.1 million USD | 1.9 million USD |
| 2008 | -3.8 million USD | 1.5 million USD |
| 2007 | -1.4 million USD | 1.0 million USD |
| 2006 | -1.9 million USD | 1.2 million USD |
| 2005 | -2.1 million USD | 903200 USD |
| 2004 | -3.1 million USD | 688377 USD |
| 2003 | -1.7 million USD | 556422 USD |
| 2002 | -2.8 million USD | 387020 USD |
| 2001 | -3.7 million USD | 151917 USD |
| 2000 | -4.9 million USD | 52492 USD |
| 1999 | -5.5 million USD | 1.0 million USD |
| 1998 | -2.1 million USD | 300000 USD |
| 1997 | -3.0 million USD | 100000 USD |
| 1996 | -2.0 million USD | 100000 USD |
| 1995 | -2.0 million USD | 100000 USD |
| 1994 | -2.4 million USD | 100000 USD |
| 1993 | -1.5 million USD | 100000 USD |
| 1992 | -1.2 million USD | 100000 USD |
| 1991 | -700000 USD | 100000 USD |
LCTX
Price: $1.14
52 week price:
Earnings Per Share: -0.12 USD
P/E Ratio: -7.54
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 400600
Market Capitalization: 245.1 million